Moody Aldrich Partners LLC Cytokinetics Inc Transaction History
Moody Aldrich Partners LLC
- $503 Million
- Q3 2024
A detailed history of Moody Aldrich Partners LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 46,731 shares of CYTK stock, worth $2.41 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
46,731
Previous 69,905
33.15%
Holding current value
$2.41 Million
Previous $3.79 Million
34.86%
% of portfolio
0.49%
Previous 0.8%
Shares
13 transactions
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.85B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...